| Year |
Citation |
Score |
| 2024 |
McCarthy AM, Ehsan S, Hughes KS, Lehman CD, Conant EF, Kontos D, Armstrong K, Chen J. Feasibility of risk assessment for breast cancer molecular subtypes. Breast Cancer Research and Treatment. PMID 38916820 DOI: 10.1007/s10549-024-07404-9 |
0.34 |
|
| 2022 |
McCarthy AM, Manning AK, Hsu S, Welch M, Moy B, Lehman CD, Armstrong K. Breast cancer polygenic risk scores are associated with short-term risk of poor prognosis breast cancer. Breast Cancer Research and Treatment. PMID 36138293 DOI: 10.1007/s10549-022-06739-5 |
0.393 |
|
| 2022 |
Marcondes FO, Armstrong K. Reducing the Burden of Overdiagnosis in Breast Cancer Screening and Beyond. Annals of Internal Medicine. 175: 598-599. PMID 35226534 DOI: 10.7326/M22-0483 |
0.362 |
|
| 2021 |
McCarthy AM, Liu Y, Ehsan S, Guan Z, Liang J, Huang T, Hughes K, Semine A, Kontos D, Conant E, Lehman C, Armstrong K, Braun D, Parmigiani G, Chen J. Validation of Breast Cancer Risk Models by Race/Ethnicity, Family History and Molecular Subtypes. Cancers. 14. PMID 35008209 DOI: 10.3390/cancers14010045 |
0.367 |
|
| 2021 |
McCarthy AM, Friebel-Klingner T, Ehsan S, He W, Welch M, Chen J, Kontos D, Domchek SM, Conant EF, Semine A, Hughes K, Bardia A, Lehman C, Armstrong K. Relationship of established risk factors with breast cancer subtypes. Cancer Medicine. PMID 34464510 DOI: 10.1002/cam4.4158 |
0.317 |
|
| 2021 |
McCarthy AM, Ehsan S, Appel S, Welch M, He W, Bahl M, Chen J, Lehman CD, Armstrong K. Risk factors for an advanced breast cancer diagnosis within 2 years of a negative mammogram. Cancer. PMID 34061353 DOI: 10.1002/cncr.33661 |
0.373 |
|
| 2020 |
McCarthy AM, Armstrong K. Genetic Testing May Help Reduce Breast Cancer Disparities for African American Women. Journal of the National Cancer Institute. PMID 32427327 DOI: 10.1093/Jnci/Djaa042 |
0.324 |
|
| 2020 |
McCarthy AM, Kumar NP, He W, Regan S, Welch M, Moy B, Iafrate AJ, Chan AT, Bardia A, Armstrong K. Different associations of tumor PIK3CA mutations and clinical outcomes according to aspirin use among women with metastatic hormone receptor positive breast cancer. Bmc Cancer. 20: 347. PMID 32326897 DOI: 10.1186/S12885-020-06810-8 |
0.319 |
|
| 2020 |
Armstrong K. Calling on Primary Care to Prevent BRCA-Related Cancers. Journal of General Internal Medicine. 35: 903-905. PMID 31637654 DOI: 10.1007/s11606-019-05469-7 |
0.355 |
|
| 2019 |
Armstrong KA. Maximizing the Outcomes of Breast Cancer Prevention. Jama Internal Medicine. 179: 1621-1623. PMID 31633744 DOI: 10.1001/jamainternmed.2019.4666 |
0.343 |
|
| 2019 |
Barlow WE, Beaber EF, Geller BM, Kamineni A, Zheng Y, Haas JS, Chao CR, Rutter CM, Zauber AG, Sprague BL, Halm EA, Weaver DL, Chubak J, Doria-Rose VP, Kobrin S, ... ... Armstrong K, et al. Evaluating screening participation, follow-up and outcomes for breast, cervical and colorectal cancer in the PROSPR consortium. Journal of the National Cancer Institute. PMID 31292633 DOI: 10.1093/Jnci/Djz137 |
0.317 |
|
| 2019 |
Schapira MM, Hubbard RA, Seitz HH, Conant EF, Schnall M, Cappella JN, Harrington T, Inge C, Armstrong K. The Impact of a Risk-Based Breast Cancer Screening Decision Aid on Initiation of Mammography Among Younger Women: Report of a Randomized Trial. Mdm Policy & Practice. 4: 2381468318812889. PMID 30729166 DOI: 10.1177/2381468318812889 |
0.366 |
|
| 2019 |
Armstrong K. Learning From Temporal Relationships: Childbirth and Breast Cancer Risk. Annals of Internal Medicine. 170: 66-67. PMID 30535335 DOI: 10.7326/M18-3455 |
0.317 |
|
| 2018 |
McCarthy AM, Barlow WE, Conant EF, Haas JS, Li CI, Sprague BL, Armstrong K. Breast Cancer With a Poor Prognosis Diagnosed After Screening Mammography With Negative Results. Jama Oncology. PMID 29801067 DOI: 10.1001/Jamaoncol.2018.0352 |
0.353 |
|
| 2018 |
Doubeni CA, Gabler NB, Wheeler CM, McCarthy AM, Castle PE, Halm EA, Schnall MD, Skinner CS, Tosteson ANA, Weaver DL, Vachani A, Mehta SJ, Rendle KA, Fedewa SA, Corley DA, ... Armstrong K, et al. Timely follow-up of positive cancer screening results: A systematic review and recommendations from the PROSPR Consortium. Ca: a Cancer Journal For Clinicians. PMID 29603147 DOI: 10.3322/Caac.21452 |
0.306 |
|
| 2017 |
Seitz HH, Schapira MM, Gibson LA, Skubisz C, Mello S, Armstrong K, Cappella JN. Explaining the effects of a decision intervention on mammography intentions: The roles of worry, fear and perceived susceptibility to breast cancer. Psychology & Health. 1-19. PMID 29073799 DOI: 10.1080/08870446.2017.1387261 |
0.304 |
|
| 2017 |
Dean LT, Moss SL, McCarthy AM, Armstrong K. Healthcare System Distrust, Physician Trust, and Patient Discordance with Adjuvant Breast Cancer Treatment Recommendations. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 28971987 DOI: 10.1158/1055-9965.Epi-17-0479 |
0.34 |
|
| 2017 |
Kim Y, McCarthy AM, Bristol M, Armstrong K. Disparities in contralateral prophylactic mastectomy use among women with early-stage breast cancer. Npj Breast Cancer. 3: 2. PMID 28649642 DOI: 10.1038/s41523-017-0004-z |
0.372 |
|
| 2017 |
Jones T, McCarthy AM, Kim Y, Armstrong K. Predictors of BRCA1/2 genetic testing among Black women with breast cancer: a population-based study. Cancer Medicine. PMID 28627138 DOI: 10.1002/Cam4.1120 |
0.349 |
|
| 2017 |
McCarthy AM, He W, Regan S, Chan AT, Moy B, Iafrate AJ, Bardia A, Armstrong K. Impact of PIK3CA tumor mutation on the association of aspirin or NSAID use and time to breast cancer recurrence. Journal of Clinical Oncology. 35: 1521-1521. DOI: 10.1200/Jco.2017.35.15_Suppl.1521 |
0.316 |
|
| 2016 |
Pollack CE, Ross ME, Armstrong K, Branas CC, Rhodes KV, Bekelman JE, Wentz A, Stillson C, Radhakrishnan A, Oyeniran E, Grande D. Using a Mystery-Caller Approach to Examine Access to Prostate Cancer Care in Philadelphia. Plos One. 11: e0164411. PMID 27723780 DOI: 10.1371/Journal.Pone.0164411 |
0.302 |
|
| 2016 |
Randall TC, Armstrong K. Health Care Disparities in Hereditary Ovarian Cancer: Are We Reaching the Underserved Population? Current Treatment Options in Oncology. 17: 39. PMID 27315065 DOI: 10.1007/s11864-016-0417-1 |
0.321 |
|
| 2016 |
McCarthy AM, Bristol M, Domchek SM, Groeneveld PW, Kim Y, Motanya UN, Shea JA, Armstrong K. Health Care Segregation, Physician Recommendation, and Racial Disparities in BRCA1/2 Testing Among Women With Breast Cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. PMID 27161971 DOI: 10.1200/Jco.2015.66.0019 |
0.379 |
|
| 2016 |
McCarthy AM, Keller BM, Pantalone LM, Hsieh MK, Synnestvedt M, Conant EF, Armstrong K, Kontos D. Racial Differences in Quantitative Measures of Area and Volumetric Breast Density. Journal of the National Cancer Institute. 108. PMID 27130893 DOI: 10.1093/Jnci/Djw104 |
0.317 |
|
| 2016 |
Conant EF, Beaber EF, Sprague BL, Herschorn SD, Weaver DL, Onega T, Tosteson AN, McCarthy AM, Poplack SP, Haas JS, Armstrong K, Schnall MD, Barlow WE. Breast cancer screening using tomosynthesis in combination with digital mammography compared to digital mammography alone: a cohort study within the PROSPR consortium. Breast Cancer Research and Treatment. PMID 26931450 DOI: 10.1007/S10549-016-3695-1 |
0.319 |
|
| 2016 |
Armstrong K, Kim JJ, Halm EA, Ballard RM, Schnall MD. Using lessons from breast, cervical, and colorectal cancer screening to inform the development of lung cancer screening programs. Cancer. PMID 26929386 DOI: 10.1002/Cncr.29937 |
0.306 |
|
| 2015 |
Epstein AJ, Wong YN, Mitra N, Vachani A, Hin S, Yang L, Smith-McLallen A, Armstrong K, Groeneveld PW. Adjuvant Chemotherapy Use and Health Care Costs After Introduction of Genomic Testing in Breast Cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. PMID 26598749 DOI: 10.1200/Jco.2015.61.9023 |
0.38 |
|
| 2015 |
Freer PE, Slanetz PJ, Haas JS, Tung NM, Hughes KS, Armstrong K, Semine AA, Troyan SL, Birdwell RL. Breast cancer screening in the era of density notification legislation: summary of 2014 Massachusetts experience and suggestion of an evidence-based management algorithm by multi-disciplinary expert panel. Breast Cancer Research and Treatment. 153: 455-64. PMID 26290416 DOI: 10.1007/s10549-015-3534-9 |
0.35 |
|
| 2015 |
Keller BM, McCarthy AM, Chen J, Armstrong K, Conant EF, Domchek SM, Kontos D. Associations between breast density and a panel of single nucleotide polymorphisms linked to breast cancer risk: a cohort study with digital mammography. Bmc Cancer. 15: 143. PMID 25881232 DOI: 10.1186/S12885-015-1159-3 |
0.351 |
|
| 2015 |
McCarthy AM, Keller B, Kontos D, Boghossian L, McGuire E, Bristol M, Chen J, Domchek S, Armstrong K. The use of the Gail model, body mass index and SNPs to predict breast cancer among women with abnormal (BI-RADS 4) mammograms. Breast Cancer Research : Bcr. 17: 1. PMID 25567532 DOI: 10.1186/S13058-014-0509-4 |
0.319 |
|
| 2015 |
Epstein A, Wong Y, Mitra N, Vachani A, Hin S, Yang L, Smith-McLallen A, Armstrong K, Groeneveld P. The impact of Genomic testing on Chemotherapy use and medical spending in a commercially-insured population of Breast Cancer Patients Value in Health. 18: A217-A218. DOI: 10.1016/J.Jval.2015.03.1262 |
0.318 |
|
| 2014 |
McCarthy AM, Armstrong K. The role of testing for BRCA1 and BRCA2 mutations in cancer prevention. Jama Internal Medicine. 174: 1023-4. PMID 24841841 DOI: 10.1001/Jamainternmed.2014.1322 |
0.36 |
|
| 2014 |
Onega T, Beaber EF, Sprague BL, Barlow WE, Haas JS, Tosteson AN, D Schnall M, Armstrong K, Schapira MM, Geller B, Weaver DL, Conant EF. Breast cancer screening in an era of personalized regimens: a conceptual model and National Cancer Institute initiative for risk-based and preference-based approaches at a population level. Cancer. 120: 2955-64. PMID 24830599 DOI: 10.1002/Cncr.28771 |
0.375 |
|
| 2014 |
McCarthy AM, Yang J, Bristol M, Conant E, Armstrong K. Abstract B85: Racial differences in false-positive mammogram rates: Results from the ACRIN Digital Mammographic Imaging Screening Trial (DMIST) Cancer Epidemiology, Biomarkers & Prevention. 23. DOI: 10.1158/1538-7755.Disp13-B85 |
0.302 |
|
| 2013 |
Vig HS, McCarthy AM, Liao K, Demeter MB, Fredericks T, Armstrong K. Age at diagnosis may trump family history in driving BRCA testing in a population of breast cancer patients. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 22: 1778-85. PMID 23917453 DOI: 10.1158/1055-9965.Epi-13-0426 |
0.31 |
|
| 2013 |
McCarthy AM, Bristol M, Fredricks T, Wilkins L, Roelfsema I, Liao K, Shea JA, Groeneveld P, Domchek SM, Armstrong K. Are physician recommendations for BRCA1/2 testing in patients with breast cancer appropriate? A population-based study. Cancer. 119: 3596-603. PMID 23861169 DOI: 10.1002/Cncr.28268 |
0.388 |
|
| 2013 |
McCarthy AM, McGuire E, Bristol M, Fredricks T, Domchek SM, Armstrong K. Agreement of self-reported hormone receptor status with cancer registry data in young breast cancer patients. Cancer Epidemiology. 37: 601-5. PMID 23810747 DOI: 10.1016/J.Canep.2013.05.010 |
0.356 |
|
| 2013 |
Armstrong K, Handorf EA, Chen J, Bristol Demeter MN. Breast cancer risk prediction and mammography biopsy decisions: a model-based study. American Journal of Preventive Medicine. 44: 15-22. PMID 23253645 DOI: 10.1016/J.Amepre.2012.10.002 |
0.334 |
|
| 2013 |
Tan AS, Moldovan-Johnson M, Gray SW, Hornik RC, Armstrong K. An analysis of the association between cancer-related information seeking and adherence to breast cancer surveillance procedures. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 22: 167-74. PMID 23118144 DOI: 10.1158/1055-9965.Epi-12-0781 |
0.382 |
|
| 2013 |
McCarthy AM, Domchek SM, Kontos D, Conant EF, Demeter MB, Jones M, Boghossian L, McGuire E, Armstrong K. Abstract 2528: Age and body mass index are predictive of cancer diagnosis among women with BIRADS 4 mammograms.: Cancer Research. 73: 2528-2528. DOI: 10.1158/1538-7445.Am2013-2528 |
0.329 |
|
| 2013 |
McCarthy AM, Demeter MB, Fredricks T, Liao K, Shea JA, Groeneveld P, Domchek SM, Armstrong K. Abstract 1358: Are physician recommendations for BRCA 1/2 testing among breast cancer patients appropriate? A population based study. Cancer Research. 73: 1358-1358. DOI: 10.1158/1538-7445.Am2013-1358 |
0.399 |
|
| 2011 |
Armstrong K, Conant E, Chen J, Handorf E, Jones M, Boghossian L, Domchek SM. Incremental impact of breast cancer SNP panel on risk classification and screening. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 1522. PMID 28024073 DOI: 10.1200/Jco.2011.29.15_Suppl.1522 |
0.347 |
|
| 2011 |
Armstrong K, Handorf E, Chen J, Bristol-Demeter M. PCN152 Can Breast Cancer Risk Prediction Reduce the Risks of False Negative and False Positive Screening Mammograms? Value in Health. 14: A462. DOI: 10.1016/J.Jval.2011.08.1253 |
0.318 |
|
| 2010 |
Nguyen GT, Shungu NP, Niederdeppe J, Barg FK, Holmes JH, Armstrong K, Hornik RC. Cancer-related information seeking and scanning behavior of older Vietnamese immigrants. Journal of Health Communication. 15: 754-68. PMID 21104504 DOI: 10.1080/10810730.2010.514034 |
0.316 |
|
| 2009 |
Shah P, Rosen M, Stopfer J, Siegfried J, Kaltman R, Mason B, Armstrong K, Nathanson KL, Schnall M, Domchek SM. Prospective study of breast MRI in BRCA1 and BRCA2 mutation carriers: effect of mutation status on cancer incidence. Breast Cancer Research and Treatment. 118: 539-46. PMID 19609668 DOI: 10.1007/S10549-009-0475-1 |
0.336 |
|
| 2009 |
Guerra CE, Sherman M, Armstrong K. Diffusion of breast cancer risk assessment in primary care. Journal of the American Board of Family Medicine : Jabfm. 22: 272-9. PMID 19429733 DOI: 10.3122/jabfm.2009.03.080153 |
0.458 |
|
| 2009 |
Gray SW, O'Grady C, Karp L, Smith D, Schwartz JS, Hornik RC, Armstrong K. Risk information exposure and direct-to-consumer genetic testing for BRCA mutations among women with a personal or family history of breast or ovarian cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 18: 1303-11. PMID 19318436 DOI: 10.1158/1055-9965.Epi-08-0825 |
0.3 |
|
| 2009 |
Mao JJ, Bowman MA, Stricker CT, DeMichele A, Jacobs L, Chan D, Armstrong K. Delivery of survivorship care by primary care physicians: the perspective of breast cancer patients. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: 933-8. PMID 19139437 DOI: 10.1200/Jco.2008.18.0679 |
0.408 |
|
| 2009 |
Berg AO, Armstrong K, Botkin J, Calonge N, Haddow J, Hayes M, Kaye C, Phillips KA, Piper M, Richards CS, Scott JA, Strickland OL, Teutsch S. Recommendations from the EGAPP Working Group: Can tumor gene expression profiling improve outcomes in patients with breast cancer? Genetics in Medicine. 11: 66-73. PMID 19125125 DOI: 10.1097/Gim.0B013E3181928F56 |
0.304 |
|
| 2008 |
Tjia J, Micco E, Armstrong K. Interest in breast cancer chemoprevention among older women. Breast Cancer Research and Treatment. 108: 435-53. PMID 17554628 DOI: 10.1007/s10549-007-9614-8 |
0.364 |
|
| 2007 |
Mao JJ, Armstrong K, Bowman MA, Xie SX, Kadakia R, Farrar JT. Symptom burden among cancer survivors: impact of age and comorbidity. Journal of the American Board of Family Medicine : Jabfm. 20: 434-43. PMID 17823460 DOI: 10.3122/Jabfm.2007.05.060225 |
0.303 |
|
| 2006 |
Armstrong K, Quistberg DA, Micco E, Domchek S, Guerra C. Prescription of tamoxifen for breast cancer prevention by primary care physicians. Archives of Internal Medicine. 166: 2260-5. PMID 17101945 DOI: 10.1001/Archinte.166.20.2260 |
0.484 |
|
| 2006 |
Gurmankin Levy A, Shea J, Williams SV, Quistberg A, Armstrong K. Measuring perceptions of breast cancer risk. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 15: 1893-8. PMID 17035396 DOI: 10.1158/1055-9965.Epi-05-0482 |
0.315 |
|
| 2006 |
Gurmankin Levy A, Micco E, Putt M, Armstrong K. Value for the future and breast cancer-preventive health behavior. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 15: 955-60. PMID 16702376 DOI: 10.1158/1055-9965.Epi-05-0169 |
0.307 |
|
| 2006 |
Domchek SM, Armstrong K, Weber BL. Clinical management of BRCA1 and BRCA2 mutation carriers. Nature Clinical Practice. Oncology. 3: 2-3. PMID 16407858 DOI: 10.1038/Sj.Onc.1209881 |
0.314 |
|
| 2006 |
Armstrong K, Gray S, Domchek S. Internet use is associated with utilization of genetic counseling for BRCA 1/2 mutations in women with a family history of breast or ovarian cancer Journal of Clinical Oncology. 24: 10654-10654. DOI: 10.1200/JCO.2006.24.18_SUPPL.10654 |
0.352 |
|
| 2005 |
Rebbeck TR, Friebel T, Wagner T, Lynch HT, Garber JE, Daly MB, Isaacs C, Olopade OI, Neuhausen SL, van 't Veer L, Eeles R, Evans DG, Tomlinson G, Matloff E, Narod SA, ... ... Armstrong K, et al. Effect of short-term hormone replacement therapy on breast cancer risk reduction after bilateral prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 23: 7804-10. PMID 16219936 DOI: 10.1200/Jco.2004.00.8151 |
0.314 |
|
| 2005 |
Gurmankin AD, Domchek S, Stopfer J, Fels C, Armstrong K. Patients' resistance to risk information in genetic counseling for BRCA1/2. Archives of Internal Medicine. 165: 523-9. PMID 15767527 DOI: 10.1001/Archinte.165.5.523 |
0.307 |
|
| 2005 |
Elmore JG, Armstrong K, Lehman CD, Fletcher SW. Screening for breast cancer. Jama. 293: 1245-56. PMID 15755947 DOI: 10.1001/JAMA.293.10.1245 |
0.325 |
|
| 2004 |
Ross S, Estok RP, Levine C, Armstrong K. Should risk factors for breast cancer influence evaluation of breast abnormalities? American Family Physician. 70: 35-6, 38. PMID 15259520 |
0.354 |
|
| 2004 |
Armstrong K. Leading the way in breast cancer screening and prevention Journal of General Internal Medicine. 19: 390-391. PMID 15061749 DOI: 10.1111/j.1525-1497.2004.42001.x |
0.359 |
|
| 2003 |
Armstrong K, Weber B, FitzGerald G, Hershey JC, Pauly MV, Lemaire J, Subramanian K, Asch DA. Life insurance and breast cancer risk assessment: adverse selection, genetic testing decisions, and discrimination. American Journal of Medical Genetics. Part A. 120: 359-64. PMID 12838555 DOI: 10.1002/Ajmg.A.20025 |
0.339 |
|
| 2003 |
Armstrong K, Weber B, Stopfer J, Calzone K, Putt M, Coyne J, Schwartz JS. Early use of clinical BRCA1/2 testing: associations with race and breast cancer risk. American Journal of Medical Genetics. Part A. 117: 154-60. PMID 12567413 DOI: 10.1002/Ajmg.A.10928 |
0.331 |
|
| 2003 |
Coyne JC, Kruus L, Racioppo M, Calzone KA, Armstrong K. What do ratings of cancer-specific distress mean among women at high risk of breast and ovarian cancer? American Journal of Medical Genetics. Part A. 222-8. PMID 12503096 DOI: 10.1002/Ajmg.A.10844 |
0.305 |
|
| 2002 |
Armstrong K, Weber B, Ubel PA, Guerra C, Schwartz JS. Interest in BRCA1/2 testing in a primary care population. Preventive Medicine. 34: 590-5. PMID 12052018 DOI: 10.1006/Pmed.2002.1022 |
0.312 |
|
| 2001 |
Armstrong K. Genetic susceptibility to breast cancer: From the roll of the dice to the hand women were dealt Journal of the American Medical Association. 285: 2907-2909. PMID 11401614 DOI: 10.1001/JAMA.285.22.2907 |
0.323 |
|
| 2001 |
Armstrong K, Weber BL. Breast cancer screening for high-risk women: too little, too late? Journal of Clinical Oncology. 19: 919-920. PMID 11181652 DOI: 10.1200/Jco.2001.19.4.919 |
0.358 |
|
| 2000 |
Armstrong K, Popik S, Guerra C, Ubel PA. Beliefs about breast cancer risk and use of postmenopausal hormone replacement therapy. Medical Decision Making : An International Journal of the Society For Medical Decision Making. 20: 308-13. PMID 10929853 DOI: 10.1177/0272989X0002000307 |
0.35 |
|
| 2000 |
Armstrong K, Eisen A, Weber B. Assessing the risk of breast cancer. The New England Journal of Medicine. 342: 564-571. PMID 10684916 DOI: 10.1056/Nejm200002243420807 |
0.441 |
|
| 2000 |
Lemaire J, Subramanian K, Armstrong K, Asch DA. Pricing Term Insurance in the Presence of a Family History of Breast or Ovarian Cancer North American Actuarial Journal. 4: 75-87. DOI: 10.1080/10920277.2000.10595904 |
0.314 |
|
| Show low-probability matches. |